Australia rolls out education

Australia’s Generic and Biosimilar Medicines Association (GBMA) has started to roll out activities under the biosimilar education grant it was awarded in April. Calling the move “a significant next step”, the GBMA said that over a three-year period, the initiative would deliver a biosimilar education programme to both Australian healthcare professionals and consumers.